Tag archive for ‘Pfizer’
Pyxis Oncology raises $152m in Series B round for cancer therapies
By businessnewstoday On Tuesday, March 30th, 2021
0 Comments

Pyxis Oncology raises $152m in Series B round for cancer therapies

(adsbygoogle = window.adsbygoogle || []).push({}); Pyxis Oncology, a Boston-based biotech company, has raised $152 million in a Series B financing round co-led by Arix Bioscience and RTW Investments. The More...

Pfizer begins phase 1 study of Covid drug candidate PF-07321332
By businessnewstoday On Wednesday, March 24th, 2021
0 Comments

Pfizer begins phase 1 study of Covid drug candidate PF-07321332

Pfizer said that it has initiated a phase 1 study in the US for assessing the oral antiviral therapeutic PF-07321332 against SARS-CoV-2, the virus that causes Covid-19. The US pharma giant said that it has completed More...

By pharmanewsdaily On Friday, February 5th, 2021
0 Comments

Pfizer withdraws application for BNT162b2 Covid-19 vaccine in India

US pharma giant Pfizer has withdrawn its application in India seeking emergency use authorization for its BNT162b2 Covid-19 vaccine. The decision to withdraw the coronavirus vaccine comes following a meeting with More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Friday, February 5th, 2021
0 Comments

Pfizer withdraws application for BNT162b2 Covid-19 vaccine in India

US pharma giant Pfizer has withdrawn its application in India seeking emergency use authorization for its BNT162b2 Covid-19 vaccine. The decision to withdraw the coronavirus vaccine comes following a meeting with More...

By pharmanewsdaily On Sunday, January 24th, 2021
0 Comments

ViiV Healthcare secures Cabenuva FDA approval for HIV-1 treatment

Cabenuva FDA approval : ViiV Healthcare has secured approval from the US Food and Drug Administration (FDA) for its long-acting regimen Cabenuva for the treatment of HIV-1 infection in adult patients. According More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Sunday, January 24th, 2021
0 Comments

ViiV Healthcare secures Cabenuva FDA approval for HIV-1 treatment

Cabenuva FDA approval : ViiV Healthcare has secured approval from the US Food and Drug Administration (FDA) for its long-acting regimen Cabenuva for the treatment of HIV-1 infection in adult patients. According More...

By pharmanewsdaily On Sunday, December 20th, 2020
0 Comments

Swissmedic authorizes use of BNT162b2 Covid-19 vaccine from Pfizer, BioNTech

Swissmedic, the Swiss Agency for Therapeutic Products, has authorized the use of the BNT162b2 Covid-19 vaccine from US pharma giant Pfizer and German biotech company BioNTech. The Swiss pharma regulator said that More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Sunday, December 20th, 2020
0 Comments

Swissmedic authorizes use of BNT162b2 Covid-19 vaccine from Pfizer, BioNTech

Swissmedic, the Swiss Agency for Therapeutic Products, has authorized the use of the BNT162b2 Covid-19 vaccine from US pharma giant Pfizer and German biotech company BioNTech. The Swiss pharma regulator said that More...

By pharmanewsdaily On Friday, December 11th, 2020
0 Comments

Pfizer and BioNTech secure FDA EUA for BNT162b2 Covid-19 vaccine

BNT162b2 FDA EUA : Pfizer and BioNTech have been granted emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for BNT162b2, their Covid-19 mRNA vaccine. BNT162b2 has been authorized by More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Friday, December 11th, 2020
0 Comments

Pfizer and BioNTech secure FDA EUA for BNT162b2 Covid-19 vaccine

BNT162b2 FDA EUA : Pfizer and BioNTech have been granted emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for BNT162b2, their Covid-19 mRNA vaccine. BNT162b2 has been authorized by More...